Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-05-18
2010-02-23
Bernhardt, Emily (Department: 1624)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C544S295000, C544S353000, C544S361000, C514S249000, C514S252180, C514S253030, C514S293000
Reexamination Certificate
active
07667039
ABSTRACT:
The invention relates to novel organic compounds of formula (I)processes for the preparation thereof, the application thereof in a process for the treatment of the human or animal body, the use thereof—alone or in combination with one or more other pharmaceutically active compounds—for the treatment of an inflammatory or obstructive airway disease, such as asthma, disorders commonly occurring in connection with transplantation, or a proliferative disease, such as a tumor disease.
REFERENCES:
patent: WO 03/097641 (2003-11-01), None
patent: WO 2005/054237 (2005-06-01), None
patent: WO 2005/054238 (2005-06-01), None
Vippagunta et al. Advanced Drug Delivery Reviews, vol. 48, pp. 3-26 (2001).
Maira et al. Expert Opin.Ther.Targets, vol. 12, p. 223-238 (2008).
Thomas et al. Current Opinion in Pharmacology, vol. 8,p. 267-274 (2008).
Crabbe et al. Trens in Biochemical Sciences, vol. 32, p. 450-456 (2007).
Furet Pascal
Garcia-Echeverria Carlos
Stauffer Frédéric
Bernhardt Emily
Manzari Oona A.
Novartis AG
LandOfFree
1,3-dihydro-imidazo [4,5-C] quinolin-2-ones as lipid kinase... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1,3-dihydro-imidazo [4,5-C] quinolin-2-ones as lipid kinase..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,3-dihydro-imidazo [4,5-C] quinolin-2-ones as lipid kinase... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4189076